Press Releases

Year 2008 | Year 2007 | Year 2006 | Year 2005 | Year 2004

• November 06, 2008
  Welichem announces 2008 AGM Board members election More...
  
  
• October 30, 2008
  Welichem Reports Positive Phase IIa Clinical Results More...
  
  
• October 06, 2008
  Dr. Yeyan Zhang Resigns as a Director More...
  
  
• September 26, 2008
  Welichem Files its Annual Audited Financials for Year Ended May 31, 2008, and Announces its AGM/SGM Date More...
  
  
• September 26, 2008
  Welichem Announces Granting of Incentive Stock Options More...
  
  
• July 08, 2008
  Welichem succesfully completes Phase I clinical trial More...
  
  
• June 27, 2008
  Welichem announces appointment of President & CEO More...
  
  
• June 20, 2008
  Welichem announces closing of non-brokered private placement More...
  
  
• June 19, 2008
  Welichem Completes Phase IIa Clinical Trial on Eczema More...
  
  
• May. 20, 2008
  Welichem announces arrangement of non-brokered private placement More...
  
  
• Apr. 25, 2008
  Welichem Filed Quarterly Report for Period Ended February 29, 2008 More...
  
  
• Apr. 08, 2008
  Dr. Hugh Wynne-Edwards Resigns as a Director and Chairman of the Board More...
  
  
• Mar. 13, 2008
  Welichem Receives Additional Contribution from NRC-IRAP to Continue Research on its Anticancer Compound, WBI-2100 More...
  
  
• Feb. 25, 2008
  Welichem Obtains Approval for Phase IIa Clinical Trial on Eczema More...
  
  
• Feb. 01, 2008
  Welichem is Participating in BioPartnering North America Conference in February, 2008 More...
  
  
• Jan. 25, 2008
  Welichem Announced Change of Board Members More...
  
  
• Jan. 25, 2008
  Welichem Filed Quarterly Report for Period Ended November 30, 2007 More...